Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 312.50 | 200.50 | 262.00 | 350.25 | 0.7480 | 0.3944 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 326.00 | 350.25 | 0.9308 | 0.8294 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 312.50 | 200.50 | 398.00 | 350.25 | 1.1363 | 1.3442 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 400.00 | 350.25 | 1.1420 | 1.3589 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 312.50 | 200.50 | 414.00 | 350.25 | 1.1820 | 1.4619 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 312.50 | 200.50 | 216.00 | 350.25 | 0.6167 | 0.0969 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 312.50 | 200.50 | 312.00 | 350.25 | 0.8908 | 0.7323 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 200.50 | 242.00 | 350.25 | 0.6909 | 0.2633 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 200.50 | 156.00 | 350.25 | 0.4454 | -0.2679 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 312.50 | 200.50 | 404.00 | 350.25 | 1.1535 | 1.3882 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 362.00 | 350.25 | 1.0335 | 1.0837 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 200.50 | 361.00 | 350.25 | 1.0307 | 1.0766 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 200.50 | 252.00 | 350.25 | 0.7195 | 0.3285 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 200.50 | 325.00 | 350.25 | 0.9279 | 0.8224 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 200.50 | 146.00 | 350.25 | 0.4169 | -0.3258 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 311.00 | 350.25 | 0.8879 | 0.7254 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 658.00 | 795.25 | 0.8274 | 0.6346 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 625.00 | 414.82 | 852.00 | 795.25 | 1.0714 | 1.1524 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 414.82 | 933.00 | 795.25 | 1.1732 | 1.3709 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 1110.00 | 795.25 | 1.3958 | 1.8528 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 625.00 | 414.82 | 833.00 | 795.25 | 1.0475 | 1.1013 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 625.00 | 414.82 | 383.00 | 795.25 | 0.4816 | -0.0815 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 884.00 | 795.25 | 1.1116 | 1.2386 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 414.82 | 1295.00 | 795.25 | 1.6284 | 2.3618 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 1103.00 | 795.25 | 1.3870 | 1.8336 |